Grass Pollen Allergy: Sublingual Immunotherapy Study

We are evaluating a new sublingual treatment for people with grass pollen allergies to see if it effectively reduces allergy symptoms. The study will also assess the safety of different doses.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Phleum Pratense Pollen Extract
Phleum pratense pollen extract is used to reduce hay fever and allergic reactions to timothy grass pollen by gradually desensitizing the immune system.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

SLI-RX-PHL

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Pneumologie, Allergologie Praxis Dr. Thomas Ginko
Pulmonary and bronchial medicine, allergology
Bonn, Germany
HNO-Praxis Dr. med. Udo Schäfer
HNO, Allergology
Dresden, Germany
Praxis für HNO und Allergologie Dr. Yury Yarin
HNO, Allergology
Mickten, Germany
Sponsor: ROXALL Medizin GmbH
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.